HomeCompareDUSA vs JNJ

DUSA vs JNJ: Dividend Comparison 2026

DUSA yields 0.97% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DUSA wins by $1.0K in total portfolio value
10 years
DUSA
DUSA
● Live price
0.97%
Share price
$50.72
Annual div
$0.49
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.0K
Annual income
$102.86
Full DUSA calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DUSA vs JNJ

📍 DUSA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDUSAJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DUSA + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DUSA pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DUSA
Annual income on $10K today (after 15% tax)
$82.12/yr
After 10yr DRIP, annual income (after tax)
$87.43/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $616.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DUSA + JNJ for your $10,000?

DUSA: 50%JNJ: 50%
100% JNJ50/50100% DUSA
Portfolio after 10yr
$20.5K
Annual income
$465.32/yr
Blended yield
2.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DUSA
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DUSA buys
0
JNJ buys
0
No recent congressional trades found for DUSA or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDUSAJNJ
Forward yield0.97%3.36%
Annual dividend / share$0.49$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$21.0K$20.0K
Annual income after 10y$102.86$827.78
Total dividends collected$1.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DUSA vs JNJ ($10,000, DRIP)

YearDUSA PortfolioDUSA Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,797$96.61$10,676$355.77+$121.00DUSA
2$11,650$97.48$11,407$389.39+$243.00DUSA
3$12,564$98.30$12,198$426.53+$366.00DUSA
4$13,542$99.08$13,056$467.62+$486.00DUSA
5$14,590$99.81$13,987$513.12+$603.00DUSA
6$15,712$100.50$14,998$563.56+$714.00DUSA
7$16,913$101.14$16,098$619.52+$815.00DUSA
8$18,198$101.75$17,295$681.69+$903.00DUSA
9$19,575$102.32$18,599$750.82+$976.00DUSA
10$21,048$102.86$20,022$827.78+$1.0KDUSA

DUSA vs JNJ: Complete Analysis 2026

DUSAStock

Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities issued by U.S. companies. The fund's portfolio generally contains between 15 and 35 companies. It may invest a portion of its assets in financial services companies. The fund may also invest in mid- and small-capitalization companies, which the manager considers to be those companies with less than $10 billion in market capitalization. It may invest up to 20% of net assets in non-U.S. companies. The fund is non-diversified.

Full DUSA Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DUSA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DUSA vs SCHDDUSA vs JEPIDUSA vs ODUSA vs KODUSA vs MAINDUSA vs ABBVDUSA vs MRKDUSA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.